Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
更正:CDK7抑制剂CT7001(Samuraciclib)靶向增殖通路以抑制晚期前列腺癌。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02606-w
Constantin, Theodora A; Varela-Carver, Anabel; Greenland, Kyle K; de Almeida, Gilberto Serrano; Olden, Ellen; Penfold, Lucy; Ang, Simon; Ormrod, Alice; Leach, Damien A; Lai, Chun-Fui; Ainscow, Edward K; Bahl, Ash K; Carling, David; Fuchter, Matthew J; Ali, Simak; Bevan, Charlotte L